| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5269797
Max Phase: Preclinical
Molecular Formula: C8H14FNO4
Molecular Weight: 207.20
Associated Items:
Representations
Canonical SMILES: OC[C@@H]1[C@@H](O)[C@H](O)[C@H]2[C@H](O)[C@@H](F)CN21
Standard InChI: InChI=1S/C8H14FNO4/c9-3-1-10-4(2-11)7(13)8(14)5(10)6(3)12/h3-8,11-14H,1-2H2/t3-,4+,5+,6+,7+,8+/m0/s1
Standard InChI Key: HVKNJBFAJLQLGG-GUHFPMLUSA-N
Associated Targets(non-human)
Alpha-glucosidase 187 Activities
Alpha-mannosidase 234 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Alpha-galactosidase 362 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Alpha-L-fucosidase 1 358 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 207.20 | Molecular Weight (Monoisotopic): 207.0907 | AlogP: -2.53 | #Rotatable Bonds: 1 |
| Polar Surface Area: 84.16 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.88 | CX Basic pKa: 6.97 | CX LogP: -2.35 | CX LogD: -2.49 |
| Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.38 | Np Likeness Score: 1.37 |
References
| 1. Li YX, Wang JZ, Shimadate Y, Kise M, Kato A, Jia YM, Fleet GWJ, Yu CY.. (2022) C-6 fluorinated casuarines as highly potent and selective amyloglucosidase inhibitors: Synthesis and structure-activity relationship study., 244 [PMID:36332547] [10.1016/j.ejmech.2022.114852] |
Source
Source(1):